Finance

Lists
Why is 2395 up 2,29%?
Dive Deeper
2395:TYO
Shin Nippon Biomedical Laboratories Ltd
1 476,00 JP¥
+2,29%
(+33,00) 1D
13-окт., 13:49:04 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 2395...
Open
1 448 JP¥
High
1 498 JP¥
Low
1 437 JP¥
Mkt. cap
61,45 млд
Avg. vol.
195,28 миң
Volume
190,80 миң
Dividend
3,39%
Quarterly dividend
13 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
11,44
52-wk high
2 005 JP¥
52-wk low
1 067 JP¥
EPS
129 JP¥
Shares outstanding
41,63 млн
No. of employees
2 миң
Open
1 448 JP¥
High
1 498 JP¥
Low
1 437 JP¥
Mkt. cap
61,45 млд
Avg. vol.
195,28 миң
Volume
190,80 миң
Dividend
3,39%
Quarterly dividend
13 JP¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
11,44
52-wk high
2 005 JP¥
52-wk low
1 067 JP¥
EPS
129 JP¥
Shares outstanding
41,63 млн
No. of employees
2 миң
News stories
From web sources and news partners
About Shin Nippon Biomedical Laboratories Ltd
CEO-
Employees1,68 миң
Founded1957
Headquarters-
SectorHealth care
Websitesnbl.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
8,29 млд
6,43 млд
11,33 млд
7,87 млд
Cost of goods sold
4,68 млд
2,20 млд
6,00 млд
3,82 млд
Cost of revenue
4,68 млд
2,20 млд
6,00 млд
3,82 млд
Research and development expenses
-
-
2,40 млд
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,22 млд
3,25 млд
850,24 млн
3,53 млд
Operating expense
3,22 млд
3,25 млд
3,70 млд
3,53 млд
Total operating expenses
7,90 млд
5,45 млд
9,70 млд
7,35 млд
Operating income
389,94 млн
978,59 млн
1,63 млд
521,74 млн
Other non operating income
54,56 млн
81,03 млн
107,77 млн
2,88 млн
EBT including unusual items
990,50 млн
1,43 млд
3,50 млд
1,41 млд
EBT excluding unusual items
1,11 млд
1,49 млд
2,71 млд
1,43 млд
Income tax expense
209,00 млн
229,77 млн
1,20 млд
345,37 млн
Effective tax rate
21,10%
16,11%
34,24%
24,52%
Other operating expenses
-
-
-
-
Net income
800,58 млн
1,21 млд
2,30 млд
1,06 млд
Net profit margin
9,66%
18,82%
20,26%
13,52%
Earnings per share
-
-
-
-
Interest and investment income
88,32 млн
14,12 млн
128,12 млн
12,42 млн
Interest expense
-68,18 млн
-78,15 млн
-88,40 млн
-106,94 млн
Net interest expenses
20,13 млн
-64,03 млн
39,72 млн
-94,52 млн
Depreciation and amortization charges
-
-
411,00 млн
-
EBITDA
1,17 млд
1,63 млд
2,48 млд
1,38 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору